Serotype III group B Streptococcus (GBS) is the major cause of neonatal meningitis, but the risk of infection in the colonized neonates is variable. Capsular sialic acid (Sia), whose synthesis is encoded by neu genes, appears to be a major virulence factor in several bacterial species able to reach the cerebrospinal fluid. Therefore, variations of Sia expression related to the genetic diversity of strains may have an impact on the risk of meningitis in colonized neonates. We characterized by MLST the phylogenetic diversity of 64 serotype III GBS strains isolated from vaginal flora and randomly selected. These strains mostly belonged to three major sequence types (STs): ST1 (11 %), ST17 (39 %) and ST19 (31 %). The genetic diversity of strains of these lineages, characterized by PFGE, allowed the selection of 17 representative strains, three ST1, six ST17 and eight ST19, with NEM316 as reference, in order to evaluate (i) by quantitative RT-PCR, the level of transcription of the neuD gene as a marker for the transcription of neu genes and (ii) by enzymological analysis, the expression of Sia. The mean transcription level of neuD was higher for ST17 strains than for ST1 and ST19 strains in the early, mid-and late exponential growth phases, and was maximum in the early exponential growth phase for ST17 strains and in the mid-exponential growth phase for ST1 and ST19 strains. Mean Sia concentration was higher for ST17 than for ST1 and ST9 strains in all three growth phases. For the total population, Sia concentration varied notably in the stationary phase, from 0.38 to 9.30 nmol per 10 8 viable bacteria, with a median value of 2.99 nmol per 10 8 bacteria. All ST17 strains, only one-third of the ST19 strains and none of the ST1 strains had Sia concentrations higher than the median Sia concentration. Therefore, differences in the level of expression of Sia by strains of the major serotype III GBS phylogenetic lineages might be one of the factors that explain the leading role of ST17 strains in neonatal meningitis.
INTRODUCTION
Streptococcus agalactiae, the group B Streptococcus (GBS), is a leading cause of invasive neonatal infections worldwide. Early-onset group B streptococcal disease (EOD) occurs in infants younger than 7 days and late-onset disease (LOD) occurs in infants between 7 and 89 days old. GBS is usually transmitted from mothers to newborns during childbirth, but it can also cross the placenta, and in LOD it can be nosocomially acquired. Classification of GBS serotypes is based on nine distinct antigenic capsular polysaccharides (Ia, Ib, II-VIII) that correlate with bacterial virulence and clinical prognosis. Five serotypes (Ia, Ib, II, III and V) are responsible for most human infections. In the USA, among EOD cases, the most frequent serotypes are Ia (30 %), III (28 %), V (18 %) and II (13 %). In contrast, in LOD, serotype III accounts for half of all cases, principally of meningitis; the remainder are predominantly serotypes Ia (24 %) and V (14 %) (Phares et al., 2008) . However, serotype distribution varies according to geographical area. In vaginal colonization, the predominant serotypes are serotypes III and Ia in the USA and in Europe, followed by serotypes II and V; in Japan, serotypes VI and VIII; in the United Arab Emirates, serotype IV; and in several African countries serotype V (Amin et al., 2002; Brochet et al., 2009; Moyo et al., 2002; Phares et al., 2008; Van der Mee-Marquet et al., 2009) . In developed countries, up to 36 % of women are colonized during pregnancy, and the vertical transmission rate to the newborn is between 50 and 70 % (Gibbs et al., 2004; Hansen et al., 2004) . Nevertheless, the incidence of neonatal infections is low (0.4 per 1000 births) (Phares et al., 2008) . The risk of developing a neonatal infection is very variable. It depends on numerous factors, including the clinical circumstances, host factors, and among colonizing strains, possible variation in the expression of virulence factors (Al Safadi et al., 2010 , 2011 Tazi et al., 2010) . The thick capsular polysaccharide (CPS) barrier anchored to the cell wall of GBS appears to be a major virulence factor (Deng et al., 2000; Rubens et al. 1987) . Each serotype expresses an antigenically unique structure, but all display terminal a-2,3-linked sialic acid (Sia) residues, which are identical with host Sia motifs and essential to GBS virulence (Lewis et al., 2004; Wessels et al., 1989) . During invasive GBS disease, Neu5Ac limits the deposition of alternative complement pathway component C3b onto the bacterial surface. This inhibition of opsonization results in decreased phagocytosis by macrophages and neutrophils (Marques et al., 1992) . Thus, the capsular Sia of GBS appears to be a determinant for survival in the host (Vimr & Lichtensteiger, 2002) .
GBS capsule biosynthesis is encoded in a single long transcript of the 16-gene cps operon. A central group of genes for serotype-specific glycosyltransferases and polymerases is flanked at the 59 end by genes suggested to function in the export of the polysaccharide capsule. Flanking the 39 end of the serotype-specific glycosyltransferase genes is a group of genes encoding enzymes that synthesize and activate Sia, the terminal sugar on the side chain of all serotypes . This group is constituted by the genes neuB, neuC, neuD and neuA, which share similarities with the Escherichia coli K1 neuABCD genes and the Neisseria meningitidis serogroup B siaCAB genes (Daines et al., 2000; Edwards et al., 1994) . The neuA gene encodes a cytosine monophosphate (CMP)-Neu5Ac synthetase, catalysing the activation of Sia with CMP (Haft et al., 1996) . The neuB gene encodes an active Neu5Ac synthase (Suryanti et al., 2003) . The neuC gene has been characterized in E. coli K1 as a UDP-N-acetylglucosamine 2-epimerase (Vann et al., 2004 (Weiman et al., 2009 (Weiman et al., , 2010 .
Among capsulated GBS strains, the serotype III strains appear to cause most invasive diseases in infants (Phares et al., 2008) . Serotype III GBS strains belong to different sequence types (STs) and are distributed among several major phylogenetic lineages or clonal complexes as shown by multilocus sequence typing (MLST) (Davies et al., 2004; Lin et al., 2006; Luan et al., 2005; Manning et al., 2009) . Analyses using PFGE, a discriminant subtyping technique, have confirmed the substantial genetic diversity of serotype III GBS strains (Gherardi et al., 2007; Martins et al., 2007) .
The genetic diversity of serotype III strains could result in notable variations in Sia expression, constituting one of the factors involved in the variability of the risk of infection in the colonized neonates. To our knowledge, the inter-and intraphylogenetic lineage variability of Sia expression of serotype III GBS has never been evaluated. To determine the degree of variation of the Sia CPS in serotype III GBS strains belonging to the vaginal flora, we investigated the transcription levels of neuD as a marker of transcription of genes encoding enzymes that synthesize and activate Sia, and also quantified the production of Sia.
METHODS

Genetic diversity and selection of GBS strains
Strains. Sixty-four serotype III GBS strains were randomly selected from an epidemiologically unrelated national collection of strains isolated from the vaginas of asymptomatic women at pre-natal screening (week 35-37) since 2003 (Loulergue et al., 2004) . Strain NEM316 (serotype III, ST23), which has been entirely sequenced, was also included and used as a reference strain (Glaser et al., 2002) .
Serotype. Strains were serotyped with a commercial latex agglutination kit (Pastorex Strepto BI, BII and BIII; Bio-Rad) and by a previously reported PCR serotype identification method, with minor modifications as described recently (Kong et al., 2002) .
MLST. The strains were analysed using MLST according to the procedure described by Jones et al. (2003) . The sequences of each new allele and the composition of new STs identified are available at http://pubmlst.org/sagalactiae/. A phylogenetic tree, based on the use of the unweighted pair group method using average linkages (UPGMA) and the Kimura two-parameter mutation model of genetic distance, was constructed from nucleotide sequences of the seven genes concatenated into a single 'supergene' (3456 bp) by use of the MEGA software version 4 (http://www.megasoftware.net).
PFGE. The aim of the PFGE was to select strains representative of the PFGE clusters of ST1, ST17 and ST19 strains. Genomic DNA was extracted from the ST1, ST17 and ST19 isolates and was digested with SmaI. It was then subjected to PFGE, as described previously (van der Mee-Marquet et al., 2009) . PFGE patterns were detected by ethidium bromide staining and UV transillumination, digitized and analysed with the Taxotron package (Taxolab; Institut Pasteur, Paris, France). The relationships between pulsotypes were determined by UPGMA and the Adanson pulsogrouping program (dissimilarity) (Taxolab). A dendrogram was drawn with Dendrograf (Taxolab).
Quantification of neuD transcripts RNA isolation. GBS strains were grown in triplicate as static cultures in 240 ml Todd-Hewitt broth at 37 uC. Samples were collected at OD 600 0.3, 0.7, and 1.2, representing early exponential (EE), mid-exponential (ME), and late exponential (LE) growth phases, respectively. An 80 ml volume of each sample was centrifuged and pellets were stored at 280 uC until processing. GBS cells were mechanically disrupted by shaking with glass beads (Tissue Lyser, Qiagen). Total RNA was extracted from the lysates with a Qiagen RNeasy Plus Mini kit according to the manufacturer's instructions (Qiagen). Residual DNA was then removed by treatment with the TurboDNA-free kit (Ambion). RNA was stored at 280 uC. RNA samples were checked for DNA contamination by PCR without prior reverse transcription (RT). As no amplicon was obtained, DNA contamination during RNA preparation could be excluded.
Reverse transcription. RT of 0.5 mg RNA was performed with random hexanucleotides and the QuantiTect Reverse Transcription kit (Qiagen) according to the manufacturer's instructions.
Quantitative real-time PCR. Appropriate primers were designed using Primer3 software (http://fokker.wi.mit.edu/primer3/): neuD1F (TGA-GCC-ATC-TTC-AAG-GTA-AGG) and neuD1R (TGC-TCC-GGT-TAT-TGA-TCC-TC). Amplification and detection of specific products was performed with the LightCycler 480 (Roche Diagnostics) with the following cycle profile: the sample was initially denatured by 1 cycle at 94 uC for 15 min, followed by 40 cycles of denaturation at 94 uC for 15 s, annealing at 50 uC for 30 s, and extension with fluorescence acquisition at 72 uC for 30 s. Meltingcurve analysis was performed between 65 and 97 uC with stepwise fluorescence acquisition and a temperature transition of 0.11 uC s 21 . To determine the relative quantity of amplified cDNA, sequencespecific standard curves were generated by 10-fold serial dilution (40 ng, 4 ng and 0.4 ng) of cDNA from GBS strain NEM316, used as the reference strain, in the EE growth phase (OD 600 0.3). The quantity (A) PFGE UPGMA trees to analyse the genetic relationships of three major STs of serotype III GBS strains. A1, relationships among seven strains of ST1. Three strains (in bold) were selected to represent the genetic diversity of serotype III GBS in order to study the transcription of neuD and the expression of Sia. A2, relationships among 20 strains of ST19. Eight strains (in bold) were selected to represent the genetic diversity of serotype III GBS in order to study the transcription of neuD and the expression of Sia. A3, relationships among 25 strains of ST17. Six strains (in bold) were selected to represent the genetic diversity of serotype III GBS in order to study the transcription of neuD and the expression of Sia. (B) Relative transcription levels of neuD in each major ST during the EE, ME and LE growth phases. The amount of neuD transcripts was normalized to the amount of gyrA transcripts and expressed relative to the level of transcription in GBS strain NEM316. Each experiment was performed at least three times. The bottom and top of each box are the 25th and 75th percentile, the band inside each box is the median, and the ends of the whiskers represent the minimum and maximum of neuD relative transcription levels in each ST in the three growth phases. B1, relative neuD transcription levels of of the three selected strains of ST1 during the EE, ME and LE growth phases. B2, relative neuD transcription levels of the eight selected strains of ST19 during the EE, ME, and LE growth phases. B3, relative neuD transcription levels of the six selected strains of ST17 during the EE, ME and LE growth phases. *The mean transcription level of neuD was significantly lower in the LE than in the EE or ME growth phases for each ST (P,0.05).
of cDNA for the neuD gene was normalized to the quantity of gyrA cDNA in each sample. The gyrA gene was chosen as the internal standard because gyrase genes are ubiquitously expressed housekeeping genes in streptococci and staphylococci, and have frequently been used for the normalization of gene expression in quantitative RT-PCR experiments (Al Safadi et al., 2010 , 2011 Gutekunst et al., 2003) . Each experiment was performed at least in triplicate. The critical threshold cycle (C t ) is defined as the cycle at which the fluorescence becomes detectable above background, and is inversely proportional to the logarithm of the initial number of template molecules. The 2 2DDCt method was used to estimate fold differences in gene expression between the vaginal GBS serotype III strains and the reference strain NEM316. To validate the 2 2DDCt method for estimating relative transcript abundance, the primers were validated to demonstrate that the efficiencies of target and reference were approximately equal and that the absolute values of the slopes of log input RNA amount versus DC t were ,0.1.
Quantification of sialic acid. For the EE and ME phases, bacteria were cultured in RPMI 1640 medium (Invitrogen), which lacks Sia Ten colonies were randomly picked, used to inoculate 20 ml of RPMI 1640 medium, and incubated until the S phase (8-9 h) at 37 uC. Cells obtained from the EE, ME and S phases were harvested by centrifugation (10 000 g, 20 min), washed twice in sterile PBS (150 mM NaCl, 10 mM sodium phosphate, pH 7.2), and adjusted to 5610 7 -1610 8 bacteria ml 21 by spectrophotometry. The viable bacterial counts were determined by plating serial dilutions onto TS agar plates.
All Sia assays were performed in triplicate. Samples (5 ml) of PBS containing 5610 7 to 1610 8 c.f.u. ml 21 were pelleted. The pellets were assayed for Sia using the Sialic Acid Quantification kit according to the manufacturer's instructions (Sigma Aldrich). Briefly, whole cells were killed by heat treatment to prevent metabolism of the free Neu5Ac. The cells were treated with a broad-spectrum neuraminidase [a-(2A3,6,8,9) -neuraminidase] to release total capsular Neu5Ac and then cells were removed by centrifugation. Variants of Neu5Ac such as O-acetylneuraminic acid were also cleaved. Free Neu5Ac in the supernatant was converted to pyruvic acid by N-acetylneuraminic acid aldolase, and then treated with lactate dehydrogenase to form lactic acid with the oxidation of b-NADH to b-NAD. b-NADH oxidation was measured spectrophotometrically. Values are reported as nmol Sia per 10 8 viable bacterial cells.
Statistical analysis. Data were analysed using Student's t-test.
When the ANOVA normality of the distribution was not respected, a non-parametric test (Kruskal-Wallis) was used. P-values ¡0.05 were considered statistically significant.
RESULTS
Genetic diversity and selection of serotype III GBS strains to study neuD gene transcription and sialic acid quantification
Genetic diversity of serotype III GBS strains. The 64 serotype III GBS strains were genetically characterized by MLST analysis with the standard MLST scheme; 12 different STs were identified. The relationships between STs, defined by UPGMA analysis, were represented as a phylogenetic tree constructed with MEGA 4 software by using the nucleotide sequences of the seven housekeeping genes concatenated into a single 'supergene' of 3456 bp (Fig. 1 ). This set of serotype III GBS isolates belonged to two major phylogenetic lineages, LI (n527 strains) and LII (n537 strains). LI was mostly composed of strains from ST17 (n525) and only two strains of ST23 (n52). LII was mostly composed of strains of ST19 (n520) and of ST1 (n57); the 10 remaining strains belonged to eight different STs. Therefore, 52 of the 64 serotype III GBS strains (81.2 %) clustered into three major STs: ST17 (39.1 %), ST19 (31.2 %) and ST1 (10.9 %).
The genetic diversity of strains within the three major STs, ST1, ST17 and ST19, was investigated by PFGE in order to select strains representative of the PFGE clusters ( Fig. 2A) . The seven ST1 strains exhibited the lowest PFGE diversity (with a maximum of 30 % dissimilarity) and were clustered in two major phylogenetic lineages (a and b). The 25 ST17 strains exhibited substantial diversity of PFGE patterns, with 24 pulsotypes with a maximum of 90 % dissimilarity. Those patterns were clustered in three major phylogenetic lineages (a, b and c). The 20 ST19 strains were distributed into 20 different pulsotypes clustering with a maximum of 60 % dissimilarity. Those patterns were clustered in three major phylogenetic lineages (a, b, and c) ( Fig. 2A) .
Selection of serotype III GBS strains to study neuD gene transcription and sialic acid quantification. On the basis of the MLST and PFGE data, we selected 17 serotype III isolates that belonged to the three major STs of the two phylogenetic lineages LI and LII. One to three strains were chosen in each major PFGE lineage in order to represent the intra-lineage genetic diversity of the three major STs. Six strains of ST17 (LI), three strains of ST1 and eight strains of ST19 (LII, n511) were selected (Figs 1 and 2 ). The serotype III ST23 strain, NEM316, was included as a reference strain.
Quantification of neuD transcripts
Variability of transcription levels of neuD among serotype III GBS strains. The mean transcription level of the neuD gene of the 17 serotype III strains quantified by real-time PCR was 0.47±0.41 in the EE growth phase, increased during ME (0.58±0.59), and decreased significantly to become weak during the LE growth phase (0.09±0.08) (EE vs LE, and ME vs LE, P,0.01) (Fig. 3) . Fig. 3 . Relative neuD transcription levels of the 17 strains (three ST1, eight ST19 and six ST17) selected to represent the genetic diversity of serotype III GBS during the EE, ME and LE growth phases. The amount of neuD transcripts was normalized to the amount of gyrA transcripts and expressed relative to the level of transcription in GBS strain NEM316. Each experiment was performed at least three times. The bottom and top of each box are the 25th and 75th percentile, the band inside each box is the median, and the ends of the whiskers represent the minimum and maximum of neuD relative transcription levels of the 17 strains in the three growth phases. *The mean transcription level of neuD was significantly lower in the LE than in the EE and ME growth phases (P,0.05). 3Mean±SD of relative neuD transcription levels.
The neuD transcript levels were variable, from 0.07 to 1.36 in the EE growth phase, and from 0.03 to 2.66 in the ME growth phase (Fig. 3) . Therefore, the neuD gene transcription level differed notably between serotype III strains.
neuD gene transcription and phylogenetic position of strains. The mean transcription level of the neuD gene of strains of each major ST during the three growth phases was compared (Table 1) . No significant difference in mean neuD transcription level between the three ST1 and the eight ST19 strains was found during the three growth phases (in EE, P50.52; in ME, P50.38; and in LE, P50.43). By contrast, the mean neuD transcription level of ST17 differed from those of ST1 and ST19. The mean neuD transcription level of ST17 was higher than those of both ST1 and ST19 in all three growth phases. It was significantly higher for ST17 vs ST19 in EE (P,0.01) and in LE (P50.05), and for ST17 vs ST1 in LE (P50.04) (Table 1) .
Similarly, neuD transcription differed between strains of the two lineages LI (ST17) and LII (ST1 and ST19) ( Table 1 ). The neuD mean transcription level in LI was significantly higher than LII during the EE (P,0.01), and LE growth phases (P50.01). In the ME growth phase, neuD was more transcribed in LI than in LII, but not significantly (P50.19) ( Table 1 ).
In addition, the kinetics and the variability of neuD transcription within the ST17 population differed notably from those of ST1 and ST19 (Table 1, Fig. 2B ). ST17 strains transcribed neuD early, with already a high level in the EE growth phase, whereas the highest neuD transcription levels were in the ME growth phase for ST1 and ST19 strains. In addition, the variability of the neuD gene transcription levels of ST17 strains was considerable in the ME growth phase (0.11 to 2.66, Fig. 2B ).
Quantification of sialic acid
Bacterial growth in RPMI 1640 medium. Bacterial growth curves in RPMI 1640 medium could not be obtained for five of the 17 selected GBS strains. Five of the eight ST19, four of the six ST17, and the three ST1 selected strains were able to achieve exponential growth in RPMI 1640 with the culture conditions used. Thus, Sia was assayed for these 12 selected strains in the EE and ME phases. Nevertheless, S phase could be obtained for all strains, and Sia was assayed for all 17 selected GBS strains in this phase.
Variability of Sia abundance in serotype III GBS strains. The Sia concentration of the 12 strains varied from 0.77 to 3.89 in the EE phase, and from 0.50 to 4.57 in the ME phase. During S phase, Sia was assayed in the 17 strains and its concentration varied notably from 0.38 to 9.30 nmol per 10 8 viable bacteria, with a median value of 2.99 nmol per 10 8 bacteria (Fig. 4) .
Sia concentration and phylogenetic position of strains. Mean Sia concentration was higher in the five ST19 strains than in the ST1 strains in the EE and ME phases, and in the eight ST19 strains than in the ST1 strains in the S phase (Fig. 4) . Nevertheless, the variability of Sia expression differed in these two populations (Fig. 4) . The Sia expression of ST1 strains was similar among the strains in the ME and S phases, whereas variations were greater in the EE phase. By contrast, Sia expression in ST19 strains was very variable in the S phase, ranging from 0.38 to 8.43 nmol per 10 8 bacteria, with a mean value of 2.89 and a SD of 2.70 nmol per 10 8 bacteria.
Mean Sia concentration was higher in ST17 than in ST1 strains in the three growth phases, and significantly higher in the ME and S phases ( Fig. 4 ; P50.03 and P50.01, respectively). It was also higher in ST17 than in ST19 strains in the three growth phases. The difference was significant at S phase ( Fig. 4 ; P50.04). It varied from 1.70 to 3.89 nmol per 10 8 bacteria in the EE phase, from 1.01 to 4.57 in the ME phase, and from 3.29 to 9.30 at S phase. Therefore, the mean Sia concentration was higher in LI than in LII in the three growth phases, and the difference was significant at S phase (5.34±2.59 vs 2.39±2.28 nmol per 10 8 bacteria; P50.02). In addition, in the S phase, as shown in Fig. 4 , all ST17 strains (100 %) had a Sia concentration higher than the median Sia concentration of the total population (2.99 nmol per 10 8 bacteria), whereas all ST1 strains (100 %) and five of the eight ST19 strains (62.5 %) had a Sia concentration lower than or equal to this median. Therefore, three of the eight ST19 strains (37.5 %) were able to produce an amount of Sia comparable with that of ST17 strains.
DISCUSSION
In developed countries, the GBS strains that possess serotype III CPS are the major cause of invasive disease in infants. Nevertheless, although women are largely colonized during pregnancy, and the vertical transmission rate to the newborn at birth is high, the incidence of neonatal infections is low (Gibbs et al., 2004; Hansen et al., 2004; Phares et al., 2008) . Several factors probably explain Table 1 . Mean transcription level of neuD in six strains of ST17 (LI phylogenetic lineage), three strains of STI and eight strains of ST19 (LII phylogenetic lineage, n511) in the EE, ME and LE growth phases the variability in the risk of developing an infectious disease in the colonized neonates, and the level of expression of CPS may be one of these factors. Indeed, nonencapsulated GBS strains are avirulent, and neonates whose mothers have low levels of CPS antibody have an increased risk of developing GBS infection (Lin et al., 2001) . Sia found in the serotype III GBS capsule is comparable to Sia found in capsules of other human meningeal pathogens, particularly E. coli K1 and N. meningitidis groups B and C. Sia is also present on most human cells and can then generate a form of molecular mimicry whereby the pathogen's resemblance to host cell surfaces blocks immune activation, and thereby plays an important role in the spread of the bacteria. Therefore, Sia would allow GBS to escape from the host immunity, and thus promote bacterial growth in the bloodstream and the crossing of the blood-brain barrier (Ferrieri et al., 1980; Join-Lambert et al., 2010; Wessels et al., 1989) . Despite its importance as an essential virulence factor, little is known about the variability of Sia expression in GBS, particularly as related to the phylogenetic diversity of strains.
In this study, we selected strains representing the genetic diversity of serotype III GBS strains, in order to determine the degree of variation of the CPS Sia, in isolates belonging to the vaginal flora from which the neonate colonization originates. We found large variations in the levels of transcription and expression of Sia. ST17 strains transcribed the neuD gene earlier and at a higher level than ST1 and ST19 strains; this may explain the highest Sia expression by ST17 strains (Figs 2 and 4, Table 1 ). Nevertheless, about a third of ST19 strains had a Sia concentration comparable with that of ST17 strains (Fig. 4) .
In GBS, the mechanisms involved in virulence are probably rather complex, on account of the fact that no particular association between virulence genes and pathogenicity, such as found in Staphylococcus aureus, Streptococcus pyogenes, Vibrio cholerae or enteric bacteria, has yet been identified (Johnson & Schlievert, 1983; Kaneko et al., 1998; Shaikh & Tarr, 2003; Waldor & Mekalanos, 1996) . The ST17 lineage of GBS strains causes significantly more meningitis in neonates than strains of other GBS lineages and hence is considered as a highly virulent clone (Héry-Arnaud et al., 2005; Manning et al., 2009) . Indeed, in several countries, ST17 strains, which are more prevalent in neonates than in pregnant women, have been isolated from the cerebrospinal fluid of neonates in more than 80 % of cases of GBS meningitis (Lin et al., 2006; Manning et al., 2009; Straková et al., 2010; Tazi et al., 2010) . In addition, ST17 strains more frequently cause meningitis than sepsis, and late onset disease (LOD) than early onset disease (EOD) (Manning et al., 2009; Tazi et al., 2010) . These data support the idea that serotype III ST17 strains have a particular ability to invade the central nervous system of the neonates. This hypothesis is consistent with studies highlighting genetic variations in virulence genes between GBS clonal groups. Indeed, several studies have demonstrated virulence gene particularities of ST17 strains: (i) a higher expression of the fibrinogen-binding gene fbsB (Al Safadi et al., 2011; Rosenau et al., 2007) , (ii) a variant of the bibA gene, encoding a cell-wall-anchored protein (HvgA) that is required for intestinal colonization and transloca- Fig. 4 . Sia concentrations of serotype III GBS strains. Each experiment was performed at least three times. The bottom and top of each box are the 25th and 75th percentile, the band inside each box is the median, and the ends of the whiskers represent the minimum and maximum of Sia concentrations. (A, B) Sia concentrations of four ST17 strains (LI phylogenetic lineage), three ST1 strains and five ST19 strains (LII phylogenetic lineage) during the EE phase (A) and the ME phase (B). (C) Sia concentrations of the 17 selected GBS strains, the six ST17 strains (LI phylogenetic lineage), the three ST1 strains, and the eight ST19 strains (LII phylogenetic lineage) during the S phase. The median Sia concentration of strains is shown by a dotted line. *The mean Sia concentration was significantly higher in the four ST17 strains than in the three ST1 strains in the ME phase (P50.03). **The mean Sia concentration was significantly higher in the six ST17 strains than in the three ST1 and eight ST19 strains, and in LI than in LII at S phase (P,0.05). 3Mean±SD of Sia concentrations in nmol per10 8 bacteria.
tion across the intestinal barrier and the blood-brain barrier leading to meningitis (Tazi et al., 2010) , and (iii) genetic variations in the serine-rich repeat region gene (srr), the surface protein gene (spb-1) and the alpha C protein gene (Brochet et al., 2006; Seifert et al., 2006) . The regulator gene configurations also vary between the ST17 strains and the other major GBS lineages. For example, ST17 strains are characterized by the presence of the rgf genes, encoding the two-component system RgfA/C that activates the fbsB gene, and the absence of rogB gene, implicated in the activation of the fbsA gene (Al Safadi et al., 2011; Gutekunst et al., 2003; Spellerberg et al., 2002) . The ability of serotype III ST17 strains to produce high concentrations of Sia, a factor found in capsules of other human pathogens particularly able to invade the central nervous system, may also be one of the factors that is involved in the particular ability of ST17 strains to be associated to meningitis.
ST19 strains are more common in EOD cases than in colonized pregnant women (Manning et al., 2009) . However, ST19 lineage strains cause significantly less EOD and LOD than ST17 lineage, and ST19 strains are less likely to cause meningitis than ST17 strains, even though these two STs share the same cps type (serotype III) (Bisharat et al., 2005; Jones et al., 2006; Lin et al., 2006; Luan et al., 2005; Manning et al., 2009) . Differences from the ST17 lineage with regard to disease pathogenesis coexist with genetic differences. ST19 strains have a configuration of the regulators of the fbs genes often characterized by the presence of the rogB gene and the absence of rgf genes (Al Safadi et al., 2011) . Moreover, while the group II intron GBSi1 marks ST17 strains, an insertion sequence, IS1548, is associated with serotype III ST19 strains, indicating that the two populations have been subjected to different horizontal genetic transfers (Héry-Arnaud et al., 2005) . This insertion sequence, located in the scp-lmb intergenic region, enhances the expression of the lmb gene, encoding laminin-binding protein, and thus may play a role in the ability of ST19 strains to cause neonatal meningitis (Al Safadi et al., 2010) . Sia expression in this ST19 lineage appears to be extremely variable and only about one-third of serotype III ST19 strains had a Sia concentration comparable to ST17 strains (Fig. 4) . These data suggest that the lower involvement of serotype III ST19 strains in neonatal meningitis than ST17 strains may be, in part, related to the low levels of Sia expressed by two-thirds of the ST19 strains. Similarly, the slight transcription of the neuD gene and the low production of Sia by the few ST1 strains having a type III CPS may explain why ST1 serotype III strains are present in pregnant women but rare among strains causing neonatal meningitis (Davies et al., 2004; Lin et al., 2006; Manning et al., 2009 ).
In conclusion, we found large variations in the levels of neuD transcription and expression of Sia among serotype III GBS strains. ST17 strains transcribed neuD earlier and at a higher level than ST1 and ST19 strains. All ST17, onethird of ST19 and none of the ST1 strains examined had high concentrations of Sia at S phase. Therefore, our data suggest that the variability of Sia expression in the various lineages that compose the serotype III GBS vaginal population might be one of the factors that explain the different roles of strains of each lineage in meningitis in neonates. Nevertheless, we do not yet understand the exact participation of the allelic variation of virulence genes, of the particular patterns of regulator genes, and of the different horizontal gene transfers marked by different mobile genetic elements in the genome, in the ability of strains to reach the cerebrospinal fluid.
